Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen

JP Mouton, K Cohen, G Maartens - Expert review of clinical …, 2016 - Taylor & Francis
Introduction: WHO recommends tenofovir, efavirenz, and lamivudine or emtricitabine for first-
line antiretroviral therapy (ART) in adults, which replaced more toxic regimens using …

Relative synonymous codon usage and codon pair analysis of depression associated genes

R Khandia, P Gurjar, MA Kamal, NH Greig - Scientific Reports, 2024 - nature.com
Depression negatively impacts mood, behavior, and mental and physical health. It is the
third leading cause of suicides worldwide and leads to decreased quality of life. We …

Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?

G Stillemans, L Belkhir, DA Hesselink… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Several antiretroviral drugs used to treat infection with the human
immunodeficiency virus (HIV) are substrates of enzymes belonging to the cytochrome P450 …

Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection

X Meng, K Yin, J Wang, P Dong, L Liu, Y Shen, L Shen… - PloS one, 2015 - journals.plos.org
Objectives The main aim of this study was to investigate the effect of CYP2B6 gene
polymorphisms on efavirenz (EFV) plasma concentrations in Han Chinese patients with …

High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections

C Sukasem, M Chamnanphon, N Koomdee… - Drug metabolism and …, 2013 - Elsevier
Efavirenz is mainly metabolized by cytochrome P450 2B6 (CYP2B6). This study aimed to
examine the frequencies of CYP2B6 and the association between CYP2B6 polymorphisms …

Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis

L Zhang, X Meng, P Dong, T Qi… - … journal of STD & …, 2023 - journals.sagepub.com
Background Tuberculosis (TB) is the leading opportunistic infection of people living with
human immunodeficiency virus (HIV; PLWH). Cytochrome P450 (CYP) 2B6 and ATP …

[HTML][HTML] Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics

V Asensi, J Collazos, E Valle-Garay - World Journal of Virology, 2015 - ncbi.nlm.nih.gov
Pharmacogenetics refers to the effect of single nucleotide polymorphisms (SNPs) within
human genes on drug therapy outcome. Its study might help clinicians to increase the …

Meta-analysis of the associations of CYP2B6-516G> T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV …

L Cheng, Y Wang, X Li, W Feng, B Weng… - The …, 2020 - nature.com
Clinical data on the relationships of cytochrome P450 (CYP2) B6 516G> T polymorphisms
with efavirenz-induced central nervous system (CNS) side effects and virological response …

[HTML][HTML] Cytochrome P450 CYP2B6* 6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection

SM Peko, NSG Gueye, C Vouvoungui… - International Journal of …, 2019 - Elsevier
Abstract Background The cytochrome P450 CYP2B6* 6 (CYP2B6 c. 516G> T; rs3745274) is
one of the genetic factors that alters the drug metabolism in antimalarial, antiretroviral and …

Caring for perinatally HIV-infected children: call for mental care for the children and the caregivers

K Kikuchi, KC Poudel, JM Rwibasira, A Majyambere… - AIDS care, 2017 - Taylor & Francis
Antiretroviral therapy has dramatically improved the survival rate of perinatally HIV-infected
children. For them to thrive, it is necessary to understand better their mental health issues …